Dicloxacillin Sodium
13412-64-1Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)[O-].[Na+]GXOMMGAFBINOJY-SLINCCQESA-MDicloxacillin sodium is an organic sodium salt. It contains a dicloxacillin(1-).
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H315 (91.5%): Causes skin irritation [Warning Skin corrosion/irritation]
P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
H315 (66.7%): Causes skin irritation [Warning Skin corrosion/irritation]
Dicloxacillin Sodium Monohydrate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Dicloxacillin sodium: Does not have an individual approval but may be used under an appropriate group standard
IMAP assessments - 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, [2S-(2.alpha.,5.alpha.,6.beta.)]-: Environment tier I assessment
IMAP assessments - 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, [2S-(2.alpha.,5.alpha.,6.beta.)]-: Human health tier I assessment
Skin Irrit. 2 (91.5%)
Skin Irrit. 2 (66.7%)
DICLOXACILLIN SODIUM
Penicillins [CS]; Penicillin-class Antibacterial [EPC]
Verwendenantibacterial
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…
13412-64-1、343-55-5DTXSID60187861CHEMBL1200701、CHEMBL26570CHEBI:34691Drug Induced Liver Injury Rank (DILIrank 2.0)
Dicloxacillin sodium
vLess-DILI-concern
3
Warnings & precautions
DOI:10.1016/j.drudis.2016.02.015